The waiting room at practically every primary care clinic in the US is packed with patients with infections, untreated pain, and illnesses that have steadily gotten worse over months until they are no longer able to be ignored. The people who arrived before the issue began will not be found at almost the same rate. Statistically speaking, those individuals don’t exist. Only about 8% of Americans receive routine preventive screenings, according to estimates derived from national surveillance data. That figure is nearly unacceptable in a country that spends more per person on healthcare than any other developed nation in the world.
There seems to be a widespread cultural belief among Americans that medicine should only be used when something goes wrong. You hold off. You put up with it. You succeed. Eventually, you leave. Even the policy discourse has found it difficult to break free from this deeply embedded pattern. The majority of clinical attention, drug funding, and healthcare research are still focused on finding a cure or treatment for diseases that have already taken hold. Research on data-driven preventive interventions is still rare in the literature. It’s not merely a scholarly observation. It reveals something genuine about the allocation of funds and the priorities set by the system.
The consequences of that choice are enormous. Missed prevention opportunities cost the US about $55 billion a year, or about 30 cents of every dollar spent on healthcare, according to estimates from the Institute of Medicine. Every year, hundreds of billions of tons of waste are incorporated into the system. Nevertheless, these numbers seldom garner the attention they merit. They appear in scholarly articles, are mentioned in policy debates, and then disappear.
The fact that the evidence supporting the effectiveness of prevention has been available for decades makes this especially frustrating. Over the course of the twentieth century, immunization programs alone decreased the yearly incidence of diseases like measles and smallpox by over 98%. Long ago, the case was resolved. Why taking action on it has been so difficult is still unknown.
There is a structural component to the solution, as well as a more immediate, household economic component. Due to the expense, about one in three American adults claim to have neglected or postponed necessary medical care in the previous 12 months. Almost half say it’s hard to afford medical care. That percentage rises to 82% among adults under 65 who lack health insurance. Rationing medications, halving pills, and using over-the-counter remedies in place of prescriptions they are unable to fill are examples of rational decisions made by individuals within an irrational system. About 40% of Americans have paid off their healthcare debt. Even those who have insurance are not protected: approximately 38% of adults with insurance worry about their monthly premium and consider their coverage to be inadequate when considering the amount they actually have to pay out-of-pocket.
It’s difficult to ignore how this manifests itself by income and race in ways that compound over time. Black adults, Hispanic adults, and lower-income households report the highest rates of chronic conditions that preventive intervention could have detected earlier, the highest rates of difficulty paying for care, and the highest rates of missing preventive screenings. Clinical data exhibits these discrepancies with a rather somber consistency. Unconventional patterns in the clustering of chronic diseases across patient populations have been revealed by machine learning research applied to national CDC datasets. These findings point to preventive care interventions that are more targeted, more predictive, and significantly less expensive than treating advanced disease. The availability of the tools is growing. Another question is whether there is the political will to use them widely.
Just 15 states out of 50 currently have preventive healthcare metrics that are higher than the national average. Fifteen. That ratio implies that information is not the issue in a nation with truly world-class data collection, computing power, and clinical expertise. It’s more akin to institutional, political, and cultural inertia. As vaccine skepticism has increased, immunization rates have been declining in some states. Between 2009 and 2017, non-medical exemptions increased in over a dozen states; this trend predated the mistrust of the Covid era and likely intensified concurrently.
For thirty years, the evidence has been quietly and steadfastly stating that prevention is more affordable, more efficient, and more equitable than treatment. The system continues to react as though it hasn’t heard anything.
